DUNE â HANDICAPPING THE WORMSIGN CNDO â The Best and Worst Case Scenarios of TRUST I, Possible Stock Outcomes and Protection Strategies â Top-line results from the TRUST I clinical trial of Coronadoâs TSO in patients with Crohnâs disease (CD) will be released in the fourth quarter. Based upon the timing of the completion of[…]
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.